Watson Pharmaceuticals, Inc. (WPI) – Major News
-
Watson Pharmaceuticals, Inc. (WPI) Tops Q3 EPS by 6c; Guides FY12 EPS Above Views
-
Watson Pharma (WPI) Raises FY12 EPS Outlook, Affirms Sales Guidance
-
Watson Pharmaceuticals, Inc. (WPI) Reports Solid Q2 Results
-
Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales
-
Watson (WPI) to Acquire Actavis in EUR 4.25B Deal; Could Be More on Performance Considerations
-
Watson Pharmaceuticals, Inc. (WPI) Tops Q4 EPS by 1c; Guides FY12 EPS
-
Watson Pharma (WPI) Preliminary FY11 Numbers Top Views; Guides FY12 EPS, Revs
-
Watson Pharmaceuticals (WPI) Tops Q3 EPS by 4c; Updates FY11 Outlook
-
Watson Pharmaceuticals (WPI) Tops Q2 EPS by 1c; Guides FY11 Sales
-
Watson Pharmaceuticals Inc. (WPI) Tops Q1 EPS by 3c; Guides In-Line
-
Watson Pharmaceuticals Inc. (WPI) Reports In-Line Q4 EPS; Guides FY11 EPS, Revs
-
Watson Pharma (WPI) Offers Guidance for FY11 EPS, Sales, EBITDA
-
Watson Pharma (WPI) Tops Q3 Views; Guides FY10
-
Watson Pharma (WPI) Posts Q2 adj.-EPS of $0.83, Tops by 2c; Guides FY10
-
Watson Pharma (WPI) Raises FY10 Outlook
-
Watson Pharma (WPI) Posts Q1 adj.-EPS of $0.81, Tops by 7c
-
Watson Pharma (WPI) Posts Q4 adj.-EPS of $0.85, Tops Views
-
Watson Pharma (WPI) Issues Preliminary FY09 Results: Sees EPS Meeting or Exceeding Prior Forecast
-
Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
-
Watson Pharma (WPI) Reports Q2 Adj-EPS of $0.61, Beats by 4c; Raises FY09 Outlook
-
Watson Pharmaceuticals (WPI) Acquires Privatly Held Arrow Group for $1.75 Billion
-
Watson Pharma (WPI) Tops Q1 Views; Raises FY09 EPS Guidance
-
Watson Pharmaceuticals (WPI) Tops Q4 EPS by 4c; Guides
-
Watson Pharmaceuticals (WPI) Tops Q3 View By A Penny
-
Watson Pharmaceuticals (WPI) Tops Q3 View By A Penny
-
Watson Pharmaceuticals (WPI) Reports Q2 EPS In-Line; Issues Guidance
-
Watson Pharmaceuticals (WPI) Tops Q1 EPS by 3c, Guides In-line for FY08
-
Watson Pharmaceuticals (WPI) Tops Q4 EPS by 4c; Guides
Back to WPI Stock Lookup